Floatz logo

cd146/her2 car-t cells

Sarcomas, Germinoblastic

Essen BiotechCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Sarcomas, Germinoblastic cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BBB
Fludarabine
University of Medicine and Dentistry of New Jersey
Phase 2BBB
DEXAMETHASONE
Mayo Clinic
Phase 2BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mayo Clinic
Phase 3BBB

View all 50 →

Same molecule, other indications

cd146/her2 car-t cells is also rated in:

Kaposi's sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →
Ewing sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →
soft tissue sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →